DERMAGEN
DermaGen develops peptide therapeutics for topical use based on novel and proprietary antimicrobial peptides (AMPs). We intend to be a leading R&D company in this area with the aim of offering innovative and profitable licensing opportunities to selected pharmaceutical companies with significant market potential. DermaGen focuses on R&D to provide new and patented products initially for dermatological indications. DermaGen has selected its first candidate drug (CD), which has entered the development phase. To help advance development of our product portfolio and to bring them to market, we welcome the interest of new investors, partners and collaborators.
DERMAGEN
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-05-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.dermagen.se
Total Employee:
1+
Status:
Closed
Contact:
+46 46 192 197
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
Investors List
Karolinska
Karolinska investment in Venture Round - DermaGen
Ostersjöstiftelsen
Ostersjöstiftelsen investment in Venture Round - DermaGen
Midroc New Technology
Midroc New Technology investment in Venture Round - DermaGen
